M Widman
Impact in
- Toxicology top 0.5%
- Forensic Toxicology and Drug Analysis
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 23
- Cannabis and Cannabinoid Research 20
-
- Alcohol Consumption and Health Effects 10
- Co-authors
- Stig Agurell (9 shared papers)Magnus M. Halldin (11 shared papers)J.‐E. Lindgren (5 shared papers)A Ohlsson (3 shared papers)Leo E. Hollister (3 shared papers)H. K. Gillespie (2 shared papers)M. Ehrnebo (1 shared paper)I. M. Nilsson (4 shared papers)
In The Last Decade
M Widman
33 papers receiving 770 citations
Peers
Comparison fields: 5 of 81
- Toxicology 218
- Pharmacology 600
- Cellular and Molecular Neuroscience 239
- Pathology and Forensic Medicine 160
- Pharmacology 65
Countries citing papers authored by M Widman
This map shows the geographic impact of M Widman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Widman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Widman more than expected).
Fields of papers citing papers by M Widman
This network shows the impact of papers produced by M Widman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Widman. The network helps show where M Widman may publish in the future.
Co-authors
The 25 scholars most cited alongside M Widman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 335 | |
| 2 | 1974 | 67 | |
| 3 | 1996 | 50 | |
| 4 | Disposition of remoxipride in different species. Species differences in metabolism. | 1993 | 41 |
| 5 | 1982 | 37 | |
| 6 | Urinary metabolites of delta 1-tetrahydrocannabinol in man. | 1982 | 33 |
| 7 | 1971 | 27 | |
| 8 | Carcinoid of esophagus. | 1969 | 23 |
| 9 | 1992 | 20 | |
| 10 | 1973 | 19 | |
| 11 | 1973 | 19 | |
| 12 | 1978 | 19 | |
| 13 | 1976 | 18 | |
| 14 | Further urinary metabolites of delta 1-tetrahydrocannabinol in man. | 1982 | 17 |
| 15 | 1990 | 15 | |
| 16 | 1978 | 12 | |
| 17 | Whole-body autoradiography of 1-tetrahydrocannabinol and 1(6)-tetrahydrocannabinol in mouse. Pharmacokinetic aspects of 1-tetrahydrocannabinol and its metabolites. | 1973 | 12 |
| 18 | 1984 | 11 | |
| 19 | 1986 | 10 | |
| 20 | 1979 | 8 |
About M Widman
M Widman is a scholar working on Pharmacology, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism, Physiology and Toxicology, having authored 33 papers that have together received 853 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (20 papers), Alcohol Consumption and Health Effects (10 papers), Diet, Metabolism, and Disease (7 papers), Forensic Toxicology and Drug Analysis (6 papers), Metabolism and Genetic Disorders (5 papers), Diet and metabolism studies (4 papers), GABA and Rice Research (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Toxicology (218 citations), Pharmacology (600 citations), Cellular and Molecular Neuroscience (239 citations), Pathology and Forensic Medicine (160 citations) and Pharmacology (65 citations). M Widman has collaborated with scholars based in Sweden, Nigeria and Uganda. Frequent co-authors include Stig Agurell, Magnus M. Halldin, J.‐E. Lindgren, A Ohlsson, Leo E. Hollister, H. K. Gillespie, M. Ehrnebo, I. M. Nilsson, Leif Nilsson and Kurt Leander. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Drug Metabolism and Disposition, Journal of Neural Transmission, Acta Anaesthesiologica Scandinavica and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.